| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 5 Jun 2025 | 5 Jun 2025 |
| In reference to captioned subject, we hereby inform you that the Board of Directors of the Company, in their Board Meeting held on June 05, 2025, at the Registered Office of the have Considered and approved, based on the recommendation of the Nomination and Remuneration Committee, appointed Mr. Kaushalkumar Shrikrishnabhai Dave (ACS 63517) as the Company Secretary and Compliance Officer of the Company with effect from 05th June, 2025. Details as required pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023 appointment of Company Secretary and Compliance Officer | ||
| Board Meeting | 29 May 2025 | 17 May 2025 |
| Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Submission of Notice convening the Board Meeting to consider and to Approve Audited Financial Results for the 4th Quarter and Year ended 31/03/2025. Outcome of the Meeting of Board of Directors held on 29th May, 2025 Consideration and Approval of Audited Financial Result for the half yearly and year ended 31st March, 2025 and Other Matters. (As Per BSE Announcement Dated on: 29/05/2025) | ||
| Board Meeting | 17 Apr 2025 | 10 Apr 2025 |
| Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/04/2025 inter alia to consider and approve Intimation of the board meeting to be held on April 17 2025. Outcome of 01st (01/2025-26) Meeting of the Board of Directors (As Per Bse Announcement Dated on 17.04.2025) | ||
| Board Meeting | 11 Dec 2024 | 11 Dec 2024 |
| Outcome of Board meeting for allotment of Bonus shares | ||
| Board Meeting | 19 Oct 2024 | 10 Oct 2024 |
| Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of the Company will be held on Saturday 19th October 2024 at the Registered office of the Company to transact following business; 1. To consider and approve the unaudited financial result of the Company for the half year ended on 30th September 2024. 2. To consider and approve Sub-Division of the face value of equity share subject to necessary approvals. 3. To consider and approve Increase in Authorized Capital of the Company subject to approval of the members; 4. To recommend and approve issue of Bonus shares post sub-division of shares to the equity shareholders of the Company. 5. To consider and approve the related party transaction disclosure under regulation 23 (9) of SEBI (Listing obligations and Disclosure Requirements) 2015 for the half year ended 30th September 2024. Outcome of the Board Meeting held on October 19, 2024 Revised outcome with Limited Review Report Results with Limited Review Report (As Per BSE Announcement Dated on 19.10.2024) | ||
| Board Meeting | 2 Sep 2024 | 27 Aug 2024 |
| Achyut Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2024 inter alia to consider and approve Dear Sir/Madam This is to inform you under Regulation 29 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of the Company will be held on Monday 02nd September 2024 at the Registered office of the Company to transact following business; 1. To call 29th Annual General Meeting of the Company and decide the time date day and venue of the meeting. 2. To consider and approve Notice of 29th Annual General Meeting & Directors Report for the year ending 31st March 2024. 3. To Appoint Mr. Kamlesh M Shah & Co. PCS as Scrutinizers for the e.voting process of the companys ensuing AGM. 4. To fix the date of Book Closure of the Company. 5. Any other item with the permission of the Chair and Majority of Directors. Outcome Of Board Meeting. (As per BSE Announcement Dated on 02/09/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.